1. Updates in Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Lymphoma and Leukemia from the Annual Meeting of American Society of Hematology 2019. (August 2020) Authors: Bukhari, Ali; Siglin, Jonathan; Lutfi, Forat; Kansagra, Ankit J.; Yared, Jean; Rapoport, Aaron P.; Dahiya, Saurabh Journal: Critical reviews in oncology/hematology Issue: Volume 152(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Severe dysautonomia as a manifestation of neurotoxicity after CAR‐T cell therapy for diffuse large B‐cell lymphoma. Issue 6 (8th April 2020) Authors: El Chaer, Firas; Siegel, Ariel; Holtzman, Noa G.; Bukhari, Ali; Lutfi, Forat; Shah, Nirav G.; Yared, Jean A.; Rapoport, Aaron P.; McCurdy, Michael T.; Dahiya, Saurabh Journal: American journal of hematology Issue: Volume 95:Issue 6(2020:Jun.) Page Start: E146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The impact of bridging therapy prior to CD19‐directed chimeric antigen receptor T‐cell therapy in patients with large B‐cell lymphoma. (9th September 2021) Authors: Lutfi, Forat; Holtzman, Noa G.; Kansagra, Ankit J.; Mustafa Ali, Moaath; Bukhari, Ali; Yan, Jingsheng; Samanta, Santanu; Gottlieb, David; Kim, Dong W.; Matsumoto, Lisa R.; Gahres, Natalie; Ruehle, Kathleen; Lee, Seung T.; Law, Jennie Y.; Kocoglu, Mehmet H.; Atanackovic, Djordje; Yared, Jean A.; H... Journal: British journal of haematology Issue: Volume 195:Number 3(2021) Page Start: 405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Chimeric antigen receptor T‐cell therapy after allogeneic stem cell transplant for relapsed/refractory large B‐cell lymphoma. (10th November 2020) Authors: Lutfi, Forat; Holtzman, Noa; Siglin, Jonathan; Bukhari, Ali; Mustafa Ali, Moaath; Kim, Dong; Sanchez‐Petitto, Gabriela; Gottlieb, David; Ruehle, Kathleen; Hutnick, Elizabeth; Gahres, Natalie; Hankey, Kim; Lee, Seung; Kocoglu, Mehmet; Yared, Jean; Hardy, Nancy; Rapoport, Aaron; Dahiya, Saurabh Journal: British journal of haematology Issue: Volume 192:Number 1(2021) Page Start: 212 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The impact of bridging therapy prior to CD19‐directed chimeric antigen receptor T‐cell therapy in patients with large B‐cell lymphoma. (9th September 2021) Authors: Lutfi, Forat; Holtzman, Noa G.; Kansagra, Ankit J.; Mustafa Ali, Moaath; Bukhari, Ali; Yan, Jingsheng; Samanta, Santanu; Gottlieb, David; Kim, Dong W.; Matsumoto, Lisa R.; Gahres, Natalie; Ruehle, Kathleen; Hankey, Kim G.; Douglas, Tracy; Lee, Seung T.; Law, Jennie Y.; Kocoglu, Mehmet H.; Atanack... Journal: British journal of haematology Issue: Volume 195:Number 3(2021) Page Start: 405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Low utility of the H-Score and HLH-2004 criteria to identify patients with secondary hemophagocytic lymphohistiocytosis after CAR-T cell therapy for relapsed/refractory diffuse large B-Cell lymphoma. Issue 6 (12th May 2022) Authors: Kim, Dong Won; Bukhari, Ali; Lutfi, Forat; Zafforoni, Facundo; Merechi, Fikru; Mustafa Ali, Moaath K.; Gottlieb, David; Lee, Seung T.; Kocoglu, Mehmet H.; Hardy, Nancy M.; Yared, Jean; Rapoport, Aaron P.; Dahiya, Saurabh; Law, Jennie Y. Journal: Leukemia & lymphoma Issue: Volume 63:Issue 6(2022) Page Start: 1339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immune effector cell–associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes. Issue 1 (5th August 2020) Authors: Holtzman, Noa G; Xie, Hao; Bentzen, Soren; Kesari, Vivek; Bukhari, Ali; El Chaer, Firas; Lutfi, Forat; Siglin, Jonathan; Hutnick, Elizabeth; Gahres, Natalie; Ruehle, Kathleen; Ahmad, Haroon; Shanholtz, Carl; Kocoglu, Mehmet H; Badros, Ashraf Z; Yared, Jean A; Hardy, Nancy M; Rapoport, Aaron P; Da... Journal: Neuro-oncology Issue: Volume 23:Issue 1(2021) Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. C-reactive protein: not always a reliable marker of ongoing cytokine release syndrome in CAR-T therapy following IL-6 blockade. Issue 9 (28th July 2020) Authors: Siglin, Jonathan; Bukhari, Ali; Lutfi, Forat; Holtzman, Noa G.; Shanholtz, Carl; Yared, Jean A.; Hardy, Nancy M.; Rapoport, Aaron P.; Dahiya, Saurabh Journal: Leukemia & lymphoma Issue: Volume 61:Issue 9(2020) Page Start: 2280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Hemophagocytic lymphohistiocytosis (HLH) presenting as fever of unknown origin and acute liver failure. (2018) Authors: Lutfi, Forat; Patel, Arpan; Becker, Dawn; Shahid, Mohammad; Shah, Kairav Journal: IDCases Issue: Volume 14(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Use of endpoints in phase III randomized controlled trials for acute myeloid leukemia over the last 15 years: a systematic review. Issue 2 (28th January 2023) Authors: Shahzad, Moazzam; Chaudhary, Sibgha Gull; Tariq, Ezza; Mushtaq, Ali Hassan; Anwar, Iqra; Ahmed, Nausheen; Bansal, Rajat; Lutfi, Forat; Balusu, Ramesh; Abdelhakim, Haitham; Yacoub, Abdulraheem; Hematti, Peiman; Singh, Anurag K.; McGuirk, Joseph P.; Mushtaq, Muhammad Umair Journal: Leukemia & lymphoma Issue: Volume 64:Issue 2(2023) Page Start: 273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗